Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-p2v8j Total loading time: 0 Render date: 2024-05-08T02:03:54.324Z Has data issue: false hasContentIssue false

8 - Androgen effects on the skin

from Section 2 - The scientific essentials

Published online by Cambridge University Press:  05 July 2015

By
Grace E. Kim  and
Alexa B. Kimball
Edited by
Leo Plouffe, Jr  and
Botros R. M. B. Rizk
Leo Plouffe, Jr
Affiliation:
Bayer Healthcare, Wayne, New Jersey
Botros R. M. B. Rizk
Affiliation:
University of South Alabama
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Androgens in Gynecological Practice , pp. 79 - 88
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Rosenfield, RL. Role of androgens in growth and development of the fetus, child, and adolescent. Adv Pediatr 1972; 19: 171–213.CrossRefGoogle Scholar
2.Zouboulis, CC, Chen, WC, Thornton, MJ, et al. Sexual hormones in human skin. Horm Metab Res 2007; 39(2): 89–95.Google Scholar
3.Rosenfield, RL. Hirsutism and the variable response of the pilosebaceous unit to androgen. J Investig Dermatol Symp Proc 2005; 10(3): 205–8.CrossRefGoogle ScholarPubMed
4.Lai, JJ, Chang, P, Lai, KP, et al. The role of androgen and androgen receptor in skin-related disorders. Arch Dermatol Res 2012; 304(7): 499–510.CrossRefGoogle ScholarPubMed
5.Deplewski, D, Rosenfield, RL. Role of hormones in pilosebaceous unit development. Endocr Rev 2000; 21(4): 363–92.Google Scholar
6.Labrie, F, Luu-The, V, Labrie, C, et al. Intracrinology and the skin. Hormone Res 2000; 54(5–6): 213–29.Google ScholarPubMed
7.Chen, W, Thiboutot, D, Zouboulis, CC. Cutaneous androgen metabolism: basic research and clinical perspectives. J Invest Dermatol 2002; 119(5): 992–1007.Google Scholar
8.Chen, W, Zouboulis, CC, Fritsch, M, et al. Evidence of heterogeneity and quantitative differences of the type 1 5alpha-reductase expression in cultured human skin cells – evidence of its presence in melanocytes. J Invest Dermatol 1998; 110(1): 84–9.CrossRefGoogle ScholarPubMed
9.Zouboulis, CC. The human skin as a hormone target and an endocrine gland. Hormones 2004; 3(1): 9–26.CrossRefGoogle Scholar
10.Gad, YZ, Berkovitz, GD, Migeon, CJ, et al. Studies of up-regulation of androgen receptors in genital skin fibroblasts. Mol Cell Endocrinol 1988; 57(3): 205–13.Google Scholar
11.Heemers, HV, Tindall, DJ. Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. Endocr Rev 2007; 28(7): 778–808.CrossRefGoogle ScholarPubMed
12.Zouboulis, CC. Human skin: an independent peripheral endocrine organ. Horm Res 2005; 54(5–6): 230–42.Google Scholar
13.Fritsch, M, Orfanos, CE, Zouboulis, CC. Sebocytes are the key regulators of androgen homeostasis in human skin. J Invest Dermatol 2001; 116(5): 793–800.CrossRefGoogle ScholarPubMed
14.Choudhry, R, Hodgins, MB, Van der Kwast, TH, et al. Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinol 1992; 133(3): 467–75.Google Scholar
15.Chen, W, Yang, C-C, Sheu, H-M, et al. Expression of peroxisome proliferator-activated receptor and CCAT/enhancer binding protein transcription factors in cultured human sebocytes. J Invest Dermatol 2003; 121(3): 441–7.CrossRefGoogle Scholar
16.Ando, Y, Yamaguchi, Y, Hamada, K, et al. Expression of mRNA for androgen receptor, 5alpha-reductase and 17beta-hydroxysteroid dehydrogenase in human dermal papilla cells. Br J Dermatol 1999; 141(5): 840–5.CrossRefGoogle Scholar
17.Kim, SS, Rosenfield, RL. Hyperhydrosis as the only manifestation of hyperandrogenism in an adolescent girl. Arch Dermatol 2000; 136(3): 430–1.CrossRefGoogle Scholar
18.Sato, K, Sato, F. Sweat secretion by human axillary apoeccrine sweat gland in vitro. Am J Physiol 1987; 252(1 Pt 2): R181–7.Google Scholar
19.Sato, T, Sonoda, T, Itami, S, et al. Predominance of type I 5alpha-reductase in apocrine sweat glands of patients with excessive or abnormal odour derived from apocrine sweat (osmodrosis). Br J Dermatol 1998; 139(5): 806–10.CrossRefGoogle ScholarPubMed
20.Preti, G, Leyden, JJ. Genetic influences on human body odor: from genes to the axillae. J Invest Dermatol 2010; 130(2): 344–6.Google Scholar
21.Kao, JS, Garg, A, Mao-Qiang, M. Testosterone perturbs epidermal permeability barrier homeostasis. J Invest Dermatol 2001; 116(3): 443–51.CrossRefGoogle ScholarPubMed
22.Cappel, M, Mauger, D, Thiboutot, D. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch Dermatol 2005; 141(3): 333–8.Google Scholar
23.Choudhry, R, Hodgins, MB, Van der Kwast, TH, et al. Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinol 1992; 133(3): 467–75.Google Scholar
24.Melnik, BC. Role of FGFR2-signaling in the pathogenesis of acne. Dermatoendocrinology 2009; 1(3): 141–56.CrossRefGoogle ScholarPubMed
25.Melnik, BC. FoxO1 – the key for the pathogenesis and therapy of acne? J Dtsch Dermatol Ges 2010; 8(2): 105–14.Google ScholarPubMed
26.Lee, WJ, Jung, HD, Chi, SG, et al. Effect of dihydrotestosterone on the regulation of inflammatory cytokines in cultured sebocytes. Arch Dermatol Res 2010; 302(6): 429–33.CrossRefGoogle Scholar
27.Goodheart, HP. Goodheart’s Photoguide of Common Skin Disorders. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2003.Google Scholar
28.Henze, C, Hinney, B, Wuttke, W. Incidence of increased androgen levels in patients suffering from acne. Dermatology 1998; 196(1): 53–4.Google Scholar
29.Arowojolu, AO, Gallo, MF, Lopez, LM, Grimes, DA. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev 2012; 7: CD004425.Google Scholar
30.Schmidt, JB. Other antiandrogens. Dermatology 1998; 196(1): 153–7.CrossRefGoogle ScholarPubMed
31.Lookingbill, DP, Abrams, BB, Ellis, CN, et al. Inocoterone and acne. The effect of a topical antiandrogen: results of a multicenter clinical trial. Arch Dermatol 1992; 128(9): 1197–200.Google Scholar
32.Melnik, BC. Isotretinoin and FoxO1: a scientific hypothesis. Dermatoendocrinology 2011; 3(3): 141–65.CrossRefGoogle ScholarPubMed
33.Olsen, EA. Androgenetic alopecia. In: Disorders of Hair Growth: Diagnosis and Treatment, Olsen, EA (Ed.), McGraw-Hill, New York, 1994. Vol. 257.Google Scholar
34.Hibberts, NA, Howell, AE, Randall, VA. Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. J Endocrinol 1998; 156(1): 59–65.CrossRefGoogle ScholarPubMed
35.Inui, S, Itami, S. Molecular basis of androgenetic alopecia: from androgen to paracrine mediators through dermal papilla. J Dermatol Sci 2011; 61(1): 1–6.Google Scholar
36.Kitagawa, T, Matsuda, K, Inui, S, et al. Keratinocyte growth inhibition through the modification of Wnt signaling by androgen in balding dermal papilla cells. J Clin Endocrinol Metab 2009; 94(4): 1288–94.Google Scholar
37.Mounsey, AL, Reed, SW. Diagnosing and treating hair loss. Am Fam Physician 2009; 80(4): 356–62.Google Scholar
38.Gilhar, A, Etzioni, A, Paus, R. Alopecia areata. N Engl J Med 2012; 366(16): 1515–25.CrossRefGoogle ScholarPubMed
39.Otberg, N, Finner, AM, Shapiro, J. Androgenetic alopecia. Endocrinol Metab Clin North Am 2007; 36(2): 379–98.Google Scholar
40.Stout, SM, Stumpf, JL. Finasteride treatment of hair loss in women. Ann Pharmacother 2010; 44(6): 1090–7.CrossRefGoogle ScholarPubMed
41.Knochenhauer, ES, Key, TJ, Kahsar-Miller, M, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998; 83(9): 3078–82.Google Scholar
42.Cebeci, F, Onsun, N, Mert, M. Insulin resistance in women with hirsutism. Arch Med Sci 2012; 8(2): 342–6.Google Scholar
43.Miller, KK, Rosner, W, Lee, H, et al. Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab 2004; 89(2): 525–33.Google Scholar
44.Moghetti, P, Castello, R, Negri, C, et al. Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behavior. Fertil Steril 1995; 64(3): 511–17.CrossRefGoogle ScholarPubMed
45.Stellon, AJ, Wakeling, M. Hidradenitis suppurativa associated with use of oral contraceptives. BMJ 1989; 298(6665): 28–9.Google Scholar
46.Harrison, BJ, Read, GF, Hughes, LE. Endocrine basis for the clinical presentation of hidradenitis suppurativa. BJS 1988; 75(10): 972–5.Google Scholar
47.Barth, JH, Layton, AM, Cunliffe, WJ. Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa. Br J Dermatol 1996; 134(6): 1057–9.Google Scholar
48.Mortimer, PS, Dawber, RPR, Gales, MA, Moore, RA. A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol 1986; 115(3): 263–8.Google Scholar
49.Jemec, GB. Clinical practice. Hidradenitis suppurativa. N Engl J Med 2012; 366: 158–64.Google Scholar
50.Kraft, JN, Searles, GE. Hidradenitis suppurativa in 64 female patients: Retrospective study comparing oral antibiotics and antiandrogen therapy. J Cutan Med Surg 2007; 11(4): 125–31.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×